BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23101443)

  • 1. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
    Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
    J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.
    Safaee M; Parsa AT; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Tihan T; Ames CP
    Neurosurg Focus; 2015 Aug; 39(2):E5. PubMed ID: 26235022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.
    Guha D; Davidson B; Nadi M; Alotaibi NM; Fehlings MG; Gentili F; Valiante TA; Tator CH; Tymianski M; Guha A; Zadeh G
    J Neurosurg; 2018 Apr; 128(4):1226-1234. PubMed ID: 28686119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
    Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
    Zehou O; Fabre E; Zelek L; Sbidian E; Ortonne N; Banu E; Wolkenstein P; Valeyrie-Allanore L
    Orphanet J Rare Dis; 2013 Aug; 8():127. PubMed ID: 23972085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience.
    Sharma MR; Puj KS; Salunke AA; Pandya SJ; Gandhi JS; Parikh AR
    J Cancer Res Ther; 2021; 17(1):106-113. PubMed ID: 33723140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
    Vasconcelos RAT; Coscarelli PG; Alvarenga RP; Acioly MA
    Arq Neuropsiquiatr; 2017 Jun; 75(6):366-371. PubMed ID: 28658406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases.
    Schmidt RF; Yick F; Boghani Z; Eloy JA; Liu JK
    Neurosurg Focus; 2013 Mar; 34(3):E5. PubMed ID: 23451818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
    Ziadi A; Saliba I
    Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
    Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
    Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological outcomes and surgical complications in 221 spinal nerve sheath tumors.
    Safaee MM; Lyon R; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Chin CT; Tihan T; Ames CP
    J Neurosurg Spine; 2017 Jan; 26(1):103-111. PubMed ID: 27472744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
    Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
    Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long survival after resection for lung metastasis of malignant peripheral nerve sheath tumor in neurofibromatosis 1.
    Shimizu K; Okita R; Uchida Y; Hihara J
    Ann Thorac Cardiovasc Surg; 2008 Oct; 14(5):322-4. PubMed ID: 18989250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.